Journalist and financial analyst Dr. Nomi Prins just announced a new webinar for April 1.

During her “Economic Super Convergence Event” webinar, Dr. Prins will discuss the top reopening plays for 2021, including the stocks, companies, and assets she believes will rise as the world exits the COVID-19 pandemic.

Should you attend Dr. Nomi Prins’ new webinar? Is the webinar really free? Find out everything you need to know about the upcoming Dr. Nomi Prins webinar today in our review.

What Are the Top Reopening Plays for 2021?

When the COVID-19 pandemic began, stocks plummeted. People sold cruise ship stocks and bank stocks. Hotel stocks dropped.

Over a year later, the COVID-19 pandemic is nearly over. The world is reopening. Vaccines are rolling out. Life is slowly getting back to normal.

Dr. Nomi Prins has identified certain stocks she believes will rise over the coming months as the world reopens.

During the April 1 webinar, Dr. Prins will discuss the best sectors and stocks investors should target as the world reopens. The event is free for anyone to attend.

About the Webinar

During her webinar on April 1, Dr. Prins will discuss the best-reopening stocks to buy for 2021, including stocks she believes will rise sharply in value before the end of the year.

Dr. Nomi Prins will discuss her biggest reopening plays of the year on Thursday, April 1, at 8 pm ET.

Anyone can attend the webinar for free just by entering their email address online. Type your email address into the online form, and you’ll receive a link to the webinar on the day it’s scheduled to take place.

What Will You Learn During the Webinar?

During the webinar, Dr. Prins will reveal one specific stock she believes is best-positioned to take advantage of America’s reopening.

Dr. Prins will reveal the name, and ticker symbol of this stock live on stage during the webinar, which will be streamed around the world for free.

Dr. Prins claims other reopening stocks have surged in recent months. Bank stocks, airline stocks, and travel-related stocks have risen by double-digit and triple-digit percentage points in recent months. It may be too late to make big gains on these stocks, but there are plenty of other opportunities for investors to buy.

Why Will Stocks Surge As America Reopens?

Stocks remained high throughout the pandemic. Aside from sector-specific crashes, investors remained confident in the world’s ability to fight the pandemic and exit it successfully.

Dr. Nomi Prins, however, believes the stock market will continue rising. By investing in the right stocks today, you could make huge returns on investment.

Why will the stock market continue to rise? Why is Dr. Prins so confident? Here’s how she explains the economic value of a reopening plan:

“The world’s largest company by market cap, Apple has reopened all 270 of its stores…Most MLB teams are welcoming fans back into the stadiums…Even Disneyland has announced its opening up again. We’re seeing all the hallmark signs of a return to better times.”

As further proof, Dr. Prins cites the Spanish Flu pandemic of 1919/1920. When that pandemic ended, America experienced a decade of extraordinary growth:

“After the Spanish Flu pandemic ended in 1920, America experienced a decade of extraordinary growth. Millionaires like J.P. Morgan Jr., John D. Rockefeller, Henry Ford, and others grew wealthier than they ever imagined.”

Based on that evidence, Dr. Prins believes “we could be on the doorsteps of a similar wealth-creating event.”

It’s Not Too Late to Invest in Post-Pandemic Recovery Stocks

Dr. Prins is releasing her webinar to reassure investors it’s not too late. Yes, certain stocks have risen sharply in recent months, fuelled by good news about vaccines. It may be too late to invest in airlines, banks, hotels, and Disney stock.

In fact, Wall Street hedge funds and major media are telling investors it’s too late to invest in post-recovery stocks. If you listened to Wall Street and the media, you’d think it’s far too late.

However, Dr. Prins believes there are plenty of other opportunities for ordinary investors:

“As someone who’s spent their entire career working inside four major Wall Street banks….and who’s invited frequently to speak on TV with the financial media…My message to you…tune out the noise. Because Wall Street and the media are going to cause you to miss the biggest opportunity of the year.”

How Much Money Can You Make?

Dr. Prins believes the post-COVID-19 recovery will create enormous gains for investors.

In fact, she claims some of her reopening stocks “could generate gains 900% larger than many popular stocks in the S&P 500 over the next few years.”

Dr. Prins is particularly confident about one stock, and she plans to reveal this stock during her presentation. She claims this stock “could end up being one of the most explosive winners in the near future” because that stock is “perfectly positioned as America reopens over the coming weeks.”

What is Dr. Prins’ Recommended Stock?

Dr. Prins will discuss one specific stock during her upcoming webinar.

Dr. Prins has not revealed that stock to us or anyone else. You’ll need to tune into her webinar on April 1 to discover the name and ticker symbol of that stock. However, she has dropped certain hints about it, including:

The stock is perfectly positioned as America reopens over the coming weeks and months

The company has a corporate client list of 120,000 customers, including some of the biggest names in the industry

The company just completed a monster quarter, raising its quarterly EPS by 227% (for perspective, Amazon’s most recent quarter had quarterly EPS growth of 116%)

Dr. Prins will reveal the name of this company – and other information – during her webinar.

Is the Economic Super Convergence Event Webinar Really Free?

Dr. Nomi’s Economic Super Convergence Event webinar is free for anyone to attend.

Just enter your email address into the online form. On April 1, you’ll receive a link in your email inbox explaining how to access the event. Just click the link, watch the live webinar, and buy Dr. Prins’ recommended stock to make huge potential gains as America recovers.

What’s the Catch?

In exchange for entering your email address into the online form, you agree to receive marketing communication from Dr. Nomi Prins and her team.

It’s unclear what type of marketing communication you will receive. However, Dr. Prins insists that “we will not share your email address with anyone.” You can also opt-out at any time, guaranteed.

There’s no other “catch” with the Economic Super Convergence Event webinar. It’s free for anyone to attend. Although you may receive advertisements for Dr. Prins’ books and other products, there’s no obligation to purchase any of these materials.

Who is Dr. Nomi Prins?

Dr. Nomi Prins is a geopolitical, financial expert and investigative journalist. She’s also a Wall Street insider and an advocate for financial reform.

You can find plenty of investment gurus online with dubious qualifications. However, Dr. Nomi Prins seems to be more qualified than other webinar hosts seen online. She was a managing director at Goldman Sachs, for example, a senior managing director at Bear Stearns and a strategist at Lehman Brothers, for example, among other financial industry positions.

In recent years, Dr. Prins has written books highlighting problems within the modern financial system, including Collusion: How Central Bankers Rigged the World and All the Presidents’ Bankers.

You can read more about Dr. Nomi Prins’ qualifications at her official website here.

Final Word

Dr. Nomi Prins has announced a webinar called the Economic Super Convergence Event.

The webinar is scheduled for Thursday, April 1, at 8 pm ET. It’s free for anyone to attend the webinar online. Just enter your email address, then wait to receive a link on April 1.

During the webinar, Dr. Prins will mention a specific stock she believes could generate huge returns for investors as America exits the pandemic. She’ll reveal the name and ticker symbol of that stock during the webinar.

Affiliate Disclosure:

The links contained in this product review may result in a small commission if you opt to purchase the product recommended at no additional cost to you. This goes towards supporting our research and editorial team and please know we only recommend high quality products.

Disclaimer:

Please understand that any advice or guidelines revealed here are not even remotely a substitute for sound medical advice from a licensed healthcare provider. Make sure to consult with a professional physician before making any purchasing decision if you use medications or have concerns following the review details shared above. Individual results may vary as the statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease.